The results of DSS analysis indicated that SLC2A1 acted as a hazard factor for patients with KIRP, LUAD, PAAD, MESO, ACC, KICH, LIHC, SARC, and BLCA (Figure S2A). This evidence concerns the gene SLC2A1 and bladder transitional cell carcinoma.